09:00 EST Day One Biopharmaceuticals (DAWN) trading resumes
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DAWN:
- Servier to acquire Day One for $21.50 per share in cash
- Day One Biopharmaceuticals trading halted, news pending
- Day One jumps 26% to $12.59 after Betaville mention
- Day One Biopharmaceuticals up 11% after rumor highlighted in Betaville blog
- Day One Biopharmaceuticals: Ojemda Uptake, Strong 2026 Guidance, and Underappreciated Emi‑Le Catalyst Support Buy Rating